A rare presentation of multiple myeloma: Tc-99m MIBI SPECT imaging of orbital involvement

References (7)

1. Fung S, Selva D, Leibovitch I, Hsuan J, Crompton J. Ophthalmic manifestations of multiple myeloma. Ophthalmologica. 2005;219(1):43-8
2. Ajithkumar TV, Sivasankar C, Ramachandran K. Orbital multiple myeloma: case report and review of computed tomography features. Australas Radiol. 2002;46(1):119-20
3. D'Sa S, Abildgaard N, Tighe J, Shaw P, Hall-Craggs M. Guidelines for the use of imaging in the management of myeloma. Br J Haematol. 2007;137(1):49 63
4. Mele A, Offidani M, Visani G et al. Technetium-99m sestamibi scintigraphy is sensitive and specific for the staging and the follow-up of patients with multiple myeloma: a multicentre study on 397 scans. Br J Haematol. 2007;136(5):729-35
5. Villa G, Balleari E, Carletto M et al.Staging and therapy monitoring of multiple myeloma by 99mTc-sestamibi scintigraphy: a five year single center experience. J Exp Clin Cancer Res. 2005;24(3):355-61
6. Catalano L, Andretta C, Pace L et al. Tc99m-sestaMIBI uptake in nonsecretory multiple myeloma. Hematology. 2005;10(4):335-8
7. Bacovsky J, Scudla V, Myslivecek M, Nekula J, Vytrasová M. Scintigraphy using (99m)Tc-MIBI (sestamibi), a sensitive parameter of activity of multiple myeloma. Neoplasma. 2005;52(4):302-6.